Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
APAC In Situ Hybridization Market by Products (Consumables, Instruments, Software), Technology (DNA FISH, RNA FISH, PNA FISH, CISH), Application (Cancer, Immunology, Neuroscience, Cytology), End User (Hospital, Pharma, Biotech, CROs) - Forecast to 2027
... Pacific in situ hybridization market is projected to reach USD 744 million by 2027 from USD 363 million in 2022, at a CAGR of 15.4% during the forecast period. Companion diagnostic products showcase a significant ... Read More
-
Global Colorectal Cancer Molecular Diagnostics Market Growth (Status and Outlook) 2023-2029
... Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected Colorectal Cancer Molecular Diagnostics sales for 2023 through 2029. With Colorectal Cancer Molecular Diagnostics sales broken down by region, market ... Read More
-
Global Follicular Lymphoma Drugs Market Growth (Status and Outlook) 2023-2029
... of white blood cell they affect. Follicular lymphoma is a non-Hodgkin's lymphoma.Drugs for Follicular lymphoma are Anti-CD20 mAbs, Chemotherapy Agents, Kinase Inhibitor, etc. LPI (LP Information)' newest research report, the “Follicular Lymphoma Drugs Industry Forecast” ... Read More
-
Global Checkpoint Inhibitors for Treating Cancer Market Growth 2023-2029
... and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the “brakes” on the immune system are released and ... Read More
-
Global In-Vitro Colorectal Cancer Screening Tests Market Growth (Status and Outlook) 2023-2029
... “In-Vitro Colorectal Cancer Screening Tests Industry Forecast” looks at past sales and reviews total world In-Vitro Colorectal Cancer Screening Tests sales in 2022, providing a comprehensive analysis by region and market sector of projected In-Vitro ... Read More
-
Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2023-2029
... from the original tumor to other locations, leading to cancer metastasis. These cells exist in peripheral blood of cancer patients and detection of CTCs can help to determine the process of metastasis. In contrast with ... Read More
-
Global Basal Cell Carcinoma Treatment Market - 2023-2030
... 2030, growing at a CAGR of 9.4% during the forecast period (2023-2030). Basal cell carcinoma (BCC) is a type of skin cancer. Basal cells, a type of skin cell that creates new skin cells as ... Read More
-
Chemotherapy Induced Peripheral Neuropathy - Drug Pipeline Landscape, 2023
... by damage to the nerves that send signals from the body to the brain. Chemotherapy-induced neuropathy is caused by a substantial number of cytotoxic drugs, including taxanes, platinums, vinca alkaloids, epothilones, eribulin, and bortezomib; these ... Read More
-
Acute Myeloid Leukemia (AML) - Drug Pipeline Landscape, 2023
... leukemia (CLL), and chronic myeloid leukemia (CML). AML is the most common type of leukemia in adults, accounting for about 80% of all cases. Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) is a type of ... Read More
-
2023 Czech Republic Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... other published source , including 2022 supplier strategies and shares, and 2022-2027 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies and ... Read More
-
Oral Mucositis - Drug Pipeline Landscape, 2023
... cause of Oral Mucositis is cancer treatments. The frequent treatments of chemotherapy, radiation of the head, chest, or neck, bone marrow and stem cell transplants can cause mucositis. Symptoms include dry mouth, shiny, swollen, or ... Read More
-
2023 Global: Anatomic Pathology Track And Trace Solutions - Innovative Markets Forecast (2029) report
... and regional data for the period 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions ... Read More
-
Bladder Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... be more than 460,000 diagnosed incident cases of bladder cancer across 16 pharmaceutical markets. There are a good number of marketed innovator drugs for the treatment of bladder cancer, mostly checkpoint inhibitors. The bladder cancer ... Read More
-
Global Peptide Cancer Vaccine Market Growth 2023-2029
... a T-cell immune response against tumor or enhancement of an endogenous antitumor immunity pre-existing in the host. LPI (LP Information)' newest research report, the “Peptide Cancer Vaccine Industry Forecast” looks at past sales and reviews ... Read More
-
Global Cancer Minimal Residual Disease Testing Market Growth 2023-2029
... result means that disease was still detected after treatment. An MRD negative result means that no disease was detected after treatment. LPI (LP Information)' newest research report, the “Cancer Minimal Residual Disease Testing Industry Forecast” ... Read More
-
Global Checkpoint Inhibitor Refractory Cancer Market Growth (Status and Outlook) 2023-2029
... Cancer sales in 2022, providing a comprehensive analysis by region and market sector of projected Checkpoint Inhibitor Refractory Cancer sales for 2023 through 2029. With Checkpoint Inhibitor Refractory Cancer sales broken down by region, market ... Read More
-
BCG Vaccine Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)
... substantial impact on the BCG vaccine market initially. The strict lockdowns and government regulations intended to slow down the spread of COVID-19 resulted in a decrease in demand for BCG vaccine due to the lack ... Read More
-
Ovarian Cancer - Drug Pipeline Landscape, 2023
... on the origination in cell types which are epithelial ovarian cancer, stromal tumor and germ cell tumor. The exact cause of Ovarian cancer is still unclear but the risk factors include family history of ovarian/breast ... Read More
-
Europe Prostate Cancer Diagnosis and Therapy Market Research Report Forecast to 2027
... a CAGR of 5.05% during the assessment period. Prostate cancer is a type of cancer that affects only males in the prostate gland cells and is highly treatable in the early stages. There are various ... Read More
-
APAC Pancreatic Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... Stage II, Stage III and Stage IV), Tumor Type(Exocrine Tumors and Neuroendocrine Tumors), Product (Instrument-Based Products, Platform-Based Products, Kits and Reagents, and Other Consumables), Technology (Fluorescent In Situ Hybridization, Next Generation Sequencing, Fluorimmunoassay, Comparative Genomic ... Read More
-
MEA Brain Cancer Diagnostic Market - Industry Trends and Forecast to 2030
... Type (Acoustic Neuroma, Astrocytomas, Glioblastoma Multiforme, Meningiomas, Oligodendroglioma, and Others), Age Group (Below 21,21-34, 35-65, and 65 and Above), End User (Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others), Country ... Read More
-
NA Throat Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... Cancer Type (Pharyngeal Cancer and Laryngeal Cancer), Stages (Stage 0, Stage I, Stage II, Stage III and Stage IV), Age Group (30-65, 65 and above, 21-29 and Below 21), End User (Hospitals, Associated Labs, Independent ... Read More
-
Europe Thyroid Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... Carcinoma, Follicular Carcinoma, Others), Stages (Stage I, Stage II, Stage III, Stage IV), Age Group (30-65, 65 and Above, 21-29, Below 21), End Users (Hospital, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research ... Read More
-
Minimal Residual Disease Market Share, Size, Trends, Industry Analysis Report, By Detection Target (Lymphoma, Leukemia, Solid Tumors, Others); By Test Technique; By End-User; By Region; Segment Forecast, 2023-2032
... is expected to reach USD 7,131.61 million by 2032, according to a new study by Polaris Market Research. The report “Minimal Residual Disease Market Share, Size, Trends, Industry Analysis Report, By Detection Target (Lymphoma, Leukemia, ... Read More
-
Global Brain Cancer Diagnostic Market - Industry Trends and Forecast to 2030
... Astrocytomas, Glioblastoma Multiforme, Meningiomas, Oligodendroglioma, and Others), Age Group (Below 21,21-34, 35-65 and 65, and Above), End User (Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others), Region (North America, Europe, ... Read More
Research Assistance
